A Living UCMSC-embedded microneedle patch for sustained extracellular vesicles delivery and functional uterine regeneration
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Extracellular vesicles in disease · Advancements in Transdermal Drug Delivery · Ultrasound and Hyperthermia Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (75)
Show source-provided references
1. Understanding the genetics of human infertility10.1126/science.adf7760 ↗
2. Age and infertility10.1136/bmj.294.6576.853 ↗
3. Thoma · 2021
4. A tissue-engineered uterus supports live births in rabbits10.1038/s41587-020-0547-7 ↗
5. Short-term and long-term effects of caesarean section on the health of women and children10.1016/S0140-6736(18)31930-5 ↗
6. Impact of Caesarean section on subsequent fertility: a systematic review and meta-analysis10.1093/humrep/det130 ↗
7. Global epidemiology of use of and disparities in caesarean sections10.1016/S0140-6736(18)31928-7 ↗
8. Cesarean section one hundred years 1920-2020: the Good, the Bad and the Ugly10.1515/jpm-2020-0305 ↗
9. i. African surgical outcomes study, perioperative patient outcomes in the African Surgical outcomes study: a 7-day prospective observational cohort study10.1016/S0140-6736(18)30001-1 ↗
10. The uterus and fertility10.1016/j.fertnstert.2007.09.069 ↗
11. Hysteroscopy in the treatment of myometrial scar defect (diverticulum) following cesarean section delivery: a systematic review and meta-analysis10.7759/cureus.11317 ↗
12. Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions10.1016/j.jconrel.2019.12.007 ↗
13. Fertile ground: human endometrial programming and lessons in health and disease10.1038/nrendo.2016.116 ↗
14. Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration
15. situ repair abilities of human umbilical cord-derived mesenchymal stem cells and autocrosslinked hyaluronic acid gel complex in rhesus monkeys with intrauterine adhesion
16. Mesenchymal stem cells therapy: a promising method for the treatment of uterine scars and premature ovarian failure10.1016/j.tice.2021.101676 ↗
17. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases10.1093/eurheartj/ehi397 ↗
18. Locoregional drug delivery for cancer therapy: preclinical progress and clinical translation10.1016/j.jconrel.2024.01.072 ↗
19. Hysteroscopic management of Asherman's syndrome10.1016/j.jmig.2017.09.020 ↗
20. Stem-cell therapy for cardiac disease10.1038/nature06800 ↗
21. Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease10.1038/s41586-025-08700-0 ↗
22. Pluripotent stem cell-based cell therapy-promise and challenges10.1016/j.stem.2020.09.014 ↗
23. Next-generation stem cells - ushering in a new era of cell-based therapies10.1038/s41573-020-0064-x ↗
24. Advances in stem cell research and therapeutic development10.1038/s41556-019-0344-z ↗
25. Pluripotent stem-cell-derived therapies in clinical trial: a 2025 update10.1016/j.stem.2024.12.005 ↗
26. An update on adipose-derived stem cells for regenerative medicine: where challenge meets opportunity
27. Mesenchymal stem cell perspective: cell biology to clinical progress10.1038/s41536-019-0083-6 ↗
28. Mesenchymal stem cells in health and disease10.1038/nri2395 ↗
29. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?10.1038/s41419-022-05034-x ↗
30. Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies10.1002/adhm.202001689 ↗
31. Mesenchymal stem cells in preclinical infertility cytotherapy: a retrospective review10.1155/2021/8882368 ↗
32. Stem cell-based therapy for human diseases10.1038/s41392-022-01134-4 ↗
33. Uterine wound healing after caesarean section: A systematic review10.1016/j.ejogrb.2024.02.045 ↗
34. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect10.1089/scd.2008.0253 ↗
35. Clinical translation of stem cell based interventions for spinal cord injury - Are we there yet?10.1016/j.addr.2017.09.021 ↗
36. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing10.1038/nm.3887 ↗
37. Porous microneedle patch with sustained delivery of extracellular vesicles mitigates severe spinal cord injury10.1038/s41467-023-39745-2 ↗
38. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity10.1016/j.biomaterials.2017.11.028 ↗
39. Therapeutically harnessing extracellular vesicles10.1038/s41573-022-00410-w ↗
40. Hypoxia-triggered self-assembly of ultrasmall iron oxide nanoparticles to amplify the imaging signal of a tumor10.1021/jacs.0c10245 ↗
41. Self-assembled copper tannic acid nanoparticles: a powerful nano-bactericide by valence shift of copper10.1016/j.nantod.2023.102071 ↗
42. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells10.1039/C5NR01084E ↗
43. Microneedle-mediated cell therapy
44. Microneedle biomedical devices10.1038/s44222-023-00141-6 ↗
45. Black phosphorus-loaded separable microneedles as responsive oxygen delivery carriers for wound healing10.1021/acsnano.0c01059 ↗
46. Bioprinted injectable hierarchically porous gelatin methacryloyl hydrogel constructs with shape-memory properties10.1002/adfm.202003740 ↗
47. Fabrication of biomedical scaffolds using biodegradable polymers10.1021/acs.chemrev.0c01200 ↗
48. Concise review: MSC-derived exosomes for cell-free therapy10.1002/stem.2575 ↗
49. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders10.1021/acsnano.9b01004 ↗
50. Engineering the MSC secretome: a hydrogel focused approach10.1002/adhm.202001948 ↗
51. Exosome processing and characterization approaches for research and technology development10.1002/advs.202103222 ↗
52. Reconstructable uterus-derived materials for uterus recovery toward efficient live births10.1002/adma.202106510 ↗
53. Enhancing stem cell survival in vivo for tissue repair10.1016/j.biotechadv.2012.11.003 ↗
54. Gynecologic postoperative anti-adhesion barriers: From biomaterials to barrier development
55. The cycling and aging mouse female reproductive tract at single-cell resolution10.1016/j.cell.2024.01.021 ↗
56. Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars10.1186/s13287-017-0535-0 ↗
57. The advance of CCN3 in fibrosis10.1007/s12079-023-00778-3 ↗
58. Slingshot isoform-specific regulation of cofilin-mediated vascular smooth muscle cell migration and neointima formation10.1161/ATVBAHA.111.232769 ↗
59. Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs10.1136/annrheumdis-2019-216108 ↗
60. Ki67 targeted strategies for cancer therapy10.1007/s12094-017-1774-3 ↗
61. Induction of anergic or regulatory tumor-specific CD4(+) T cells in the tumor-draining lymph node10.1038/s41467-018-04524-x ↗
62. Inflammation and uterine fibrosis: the possible role of chronic endometritis10.1016/j.fertnstert.2019.02.005 ↗
63. TGFbeta suppresses CD8(+) T cell expression of CXCR3 and tumor trafficking10.1038/s41467-020-15404-8 ↗
64. p38alpha: a profibrotic signaling nexus10.1161/CIRCULATIONAHA.117.028957 ↗
65. TGF-Beta signaling manipulation as potential therapy for IBD10.2174/13894501113149990157 ↗
66. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-beta1/Smad pathway and promote repair of damaged endometrium10.1186/s13287-019-1332-8 ↗
67. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor beta signaling in human endometrial stromal cells10.1093/humrep/dez001 ↗
68. Overexpressing TGF-beta1 in mesenchymal stem cells attenuates organ dysfunction during CLP-induced septic mice by reducing macrophage-driven inflammation10.1186/s13287-020-01894-2 ↗
69. Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy10.1038/s41419-021-03883-6 ↗
70. Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice10.1038/s41419-021-03839-w ↗
71. vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model10.1016/j.jconrel.2018.04.020 ↗
72. Recent trends in the development of peptide and protein-based hydrogel therapeutics for the healing of CNS injury10.1039/D0SM00885K ↗
73. Antioxidant nanozyme microneedles with stem cell loading for in situ endometrial repair10.1016/j.cej.2022.137786 ↗
74. Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway10.1038/s41419-019-1928-z ↗
75. Endometrial stem cells repair injured endometrium and induce angiogenesis via AKT and ERK pathways10.1530/REP-16-0286 ↗